By enhancing oxygen delivery, reducing inflammation, supporting neurological health, and promoting cellular repair, HBOT can contribute to symptom relief and an improved quality of life for individuals with Lyme disease.
By adhering to rigorous safety standards, ensuring consistent treatment quality, and providing accurate treatment parameters, FDA approval offers peace of mind and confidence in the therapy.
By enhancing oxygen delivery, reducing inflammation, supporting vascular health, and promoting cellular repair, HBOT can contribute to better outcomes and improved quality of life for individuals with CKD.
